Related Experiment Video
Updated: Apr 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory markers in ST-elevation acute myocardial infarction
Ignacio M Seropian1, Chiara Sonnino2, Benjamin W Van Tassell3
1Interventional Cardiology Department, Hospital Italiano de Buenos Aires, Argentina.
Inflammatory markers, including leukocyte count, predict adverse outcomes after ST-elevation myocardial infarction. These biomarkers help identify patients at higher risk for heart failure and sudden death.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- Ventricular remodeling post-myocardial infarction influences heart failure progression.
- Inflammation is crucial in wound healing and scar formation, impacting ventricular remodeling.
Purpose of the Study:
- To review the value of inflammatory markers in ST-elevation acute myocardial infarction (STEMI).
- To assess the association of inflammatory markers with ventricular remodeling, heart failure, and sudden death.
Main Methods:
- Analysis of various inflammatory response components as biomarkers in STEMI patients.
- Inclusion of readily available tests (leukocyte count) and sophisticated immunoassays.
Main Results:
- Inflammatory markers, including leukocyte count, are powerful predictors of adverse outcomes in STEMI.
- These markers are associated with ventricular remodeling, heart failure, and sudden death.
Conclusions:
- Inflammatory biomarkers can identify STEMI patients at greater risk of adverse events.
- These markers may offer insights into the mechanisms of disease progression.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations